Hey y'all:
Sorry for the delay, but it's next to impossible to find folks on Easter Monday. Anyway, I believe you made a good call Ram. Wish I had any more loose change to add to the pot. What I can gather, in a nutshell:
1. The Biotrack acquisition has been approved. PDTI has received outside capital and either has or will make its first partial payment soon.
2. Sorry, I can't get the name of the funding agent or company. And alas, I don't know how it will be repaid, whether in shares of stock or as a business loan.
3. Either way, it clears two major hurdles for the company. It creates a new overseas market and provides a source of ongoing income.
What remains, IMO, is to integrate the product lines, get the FDA waiver on Stat-K license requirements and quietly map out your marketing base. Of course, if I was so smart, I'd be rich (gg).
Anyway, we're on track -- biotrack, that is. Have a pleasant day and congrats to any Arizona fans out there.
Chick in NC (hey, at least my team got to the Sweet 16) |